Literature DB >> 21085994

High resolution mapping of OCA2 intragenic rearrangements and identification of a founder effect associated with a deletion in Polish albino patients.

Caroline Rooryck1, Fanny Morice-Picard, Eulalie Lasseaux, Dorothée Cailley, Hélène Dollfus, Sabine Defoort-Dhellemme, Bénédicte Duban-Bedu, Thomy J L de Ravel, Alain Taieb, Didier Lacombe, Benoît Arveiler.   

Abstract

Oculocutaneous albinism type 2 (OCA2) represents about 30% of OCA worldwide. Using quantitative multiplex fluorescent PCR and very high-resolution array-CGH focussed on the OCA2 gene and surrounding regions in 15q12, we identified new rearrangements. Deletion 1, encompassing exons 3-20, was present in three patients (including one in the homozygous state), and Deletion 2 (exons 1-20) was found in one patient (heterozygous state). The duplication (exons 3-20) was found in one patient in the homozygous state. Using 14 microsatellite markers we determined haplotypes associated with these rearrangements. Deletion 1 was associated with the same haplotype in three patients who were all of Polish origin, which is strongly in favour of a founder effect. Deletion 2 was associated with a distinct haplotype. The homozygous duplication was inherited from the two unrelated parents of the patients on two different haplotypes. Analysis of the sequences around the breakpoints of these rearrangements showed that all occurred within complex arrays of repetitive sequences. The combined use of very high-resolution array-CGH and of microsatellites (including new intragenic ones described here) constitutes a powerful approach for the precise characterization of OCA2 rearrangements, which have been found in more than 20% of OCA2 patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21085994     DOI: 10.1007/s00439-010-0913-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  Oculocutaneous albinism type 2 with a P gene missense mutation in a patient with Angelman syndrome.

Authors:  S Saitoh; N Oiso; T Wada; O Narazaki; K Fukai
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

2.  A 122.5-kilobase deletion of the P gene underlies the high prevalence of oculocutaneous albinism type 2 in the Navajo population.

Authors:  Zanhua Yi; Nanibaa' Garrison; Orit Cohen-Barak; Tatiana M Karafet; Richard A King; Robert P Erickson; Michael F Hammer; Murray H Brilliant
Journal:  Am J Hum Genet       Date:  2002-12-05       Impact factor: 11.025

3.  P gene mutations associated with oculocutaneous albinism type II (OCA2).

Authors:  William S Oetting; Sarah Savage Garrett; Marcia Brott; Richard A King
Journal:  Hum Mutat       Date:  2005-03       Impact factor: 4.878

4.  Duplication of 15q11.2-q14, including the P gene, in a woman with generalized skin hyperpigmentation.

Authors:  K Akahoshi; K Fukai; A Kato; S Kimiya; T Kubota; R A Spritz
Journal:  Am J Med Genet       Date:  2001-12-15

5.  Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects.

Authors:  Caroline Rooryck; Fanny Morice-Picard; Nursel H Elçioglu; Didier Lacombe; Alain Taieb; Benoît Arveiler
Journal:  Pigment Cell Melanoma Res       Date:  2008-10       Impact factor: 4.693

6.  Estimation of carrier frequency of a 2.7 kb deletion allele of the P gene associated with OCA2 in African-Americans.

Authors:  D Durham-Pierre; R A King; J M Naber; S Laken; M H Brilliant
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

Review 7.  Mechanisms of change in gene copy number.

Authors:  P J Hastings; James R Lupski; Susan M Rosenberg; Grzegorz Ira
Journal:  Nat Rev Genet       Date:  2009-08       Impact factor: 53.242

8.  Angelman syndrome associated with oculocutaneous albinism due to an intragenic deletion of the P gene.

Authors:  C Fridman; N Hosomi; M C Varela; A H Souza; K Fukai; C P Koiffmann
Journal:  Am J Med Genet A       Date:  2003-06-01       Impact factor: 2.802

9.  African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.

Authors:  D Durham-Pierre; J M Gardner; Y Nakatsu; R A King; U Francke; A Ching; R Aquaron; V del Marmol; M H Brilliant
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

Review 10.  Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes.

Authors:  James R Lupski; Pawel Stankiewicz
Journal:  PLoS Genet       Date:  2005-12       Impact factor: 5.917

View more
  7 in total

1.  Clinical evaluation and molecular screening of a large consecutive series of albino patients.

Authors:  Lucia Mauri; Emanuela Manfredini; Alessandra Del Longo; Emanuela Veniani; Manuela Scarcello; Roberta Terrana; Adriano Egidio Radaelli; Donata Calò; Giuseppe Mingoia; Antonella Rossetti; Giovanni Marsico; Marco Mazza; Giovanni Pietro Gesu; Maria Cristina Patrosso; Silvana Penco; Elena Piozzi; Paola Primignani
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

2.  Discovery of variants unmasked by hemizygous deletions.

Authors:  Ron Hochstenbach; Martin Poot; Isaac J Nijman; Ivo Renkens; Karen J Duran; Ruben Van't Slot; Ellen van Binsbergen; Bert van der Zwaag; Maartje J Vogel; Paulien A Terhal; Hans Kristian Ploos van Amstel; Wigard P Kloosterman; Edwin Cuppen
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

Review 3.  Mechanisms of Origin, Phenotypic Effects and Diagnostic Implications of Complex Chromosome Rearrangements.

Authors:  Martin Poot; Thomas Haaf
Journal:  Mol Syndromol       Date:  2015-08-15

Review 4.  DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics.

Authors:  Dimitre R Simeonov; Xinjing Wang; Chen Wang; Yuri Sergeev; Monika Dolinska; Matthew Bower; Roxanne Fischer; David Winer; Genia Dubrovsky; Joan Z Balog; Marjan Huizing; Rachel Hart; Wadih M Zein; William A Gahl; Brian P Brooks; David R Adams
Journal:  Hum Mutat       Date:  2013-04-30       Impact factor: 4.878

5.  A custom capture sequence approach for oculocutaneous albinism identifies structural variant alleles at the OCA2 locus.

Authors:  Stacie K Loftus; Linnea Lundh; Dawn E Watkins-Chow; Laura L Baxter; Erola Pairo-Castineira; Ian J Jackson; William S Oetting; William J Pavan; David R Adams
Journal:  Hum Mutat       Date:  2021-08-01       Impact factor: 4.700

6.  Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report.

Authors:  Hairong Wang; Yang Wan; Yun Yang; Hao Li; Liangwei Mao; Shuyang Gao; Jingjing Xu; Jing Wang
Journal:  BMC Med Genet       Date:  2019-07-25       Impact factor: 2.103

7.  Mutational analysis of a Chinese family with oculocutaneous albinism type 2.

Authors:  Xiong Wang; Yaowu Zhu; Na Shen; Jing Peng; Chunyu Wang; Haiyi Liu; Yanjun Lu
Journal:  Oncotarget       Date:  2017-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.